BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34480014)

  • 1. miR-98-5p plays a critical role in depression and antidepressant effect of ketamine.
    Huang C; Wang Y; Wu Z; Xu J; Zhou L; Wang D; Yang L; Zhu B; Chen G; Liu C; Yang C
    Transl Psychiatry; 2021 Sep; 11(1):454. PubMed ID: 34480014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats.
    Wan YQ; Feng JG; Li M; Wang MZ; Liu L; Liu X; Duan XX; Zhang CX; Wang XB
    Exp Mol Med; 2018 Oct; 50(10):1-14. PubMed ID: 30369596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice.
    Ma L; Wang L; Chang L; Shan J; Qu Y; Wang X; Wan X; Fujita Y; Hashimoto K
    Transl Psychiatry; 2022 Sep; 12(1):417. PubMed ID: 36171191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
    Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K
    Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
    Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.
    Yang C; Yang J; Luo A; Hashimoto K
    Transl Psychiatry; 2019 Nov; 9(1):280. PubMed ID: 31699965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanosine potentiates the antidepressant-like effect of subthreshold doses of ketamine: Possible role of pro-synaptogenic signaling pathway.
    Camargo A; Dalmagro AP; Zeni ALB; Rodrigues ALS
    J Affect Disord; 2020 Jun; 271():100-108. PubMed ID: 32479304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
    Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
    Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.
    Burgdorf J; Zhang XL; Nicholson KL; Balster RL; Leander JD; Stanton PK; Gross AL; Kroes RA; Moskal JR
    Neuropsychopharmacology; 2013 Apr; 38(5):729-42. PubMed ID: 23303054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine induces rapid and sustained antidepressant-like effects in chronic pain induced depression: Role of MAPK signaling pathway.
    Humo M; Ayazgök B; Becker LJ; Waltisperger E; Rantamäki T; Yalcin I
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109898. PubMed ID: 32109506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
    Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model.
    Ma L; Wang L; Chang L; Shan J; Qu Y; Wang X; Fujita Y; Hashimoto K
    Neuropharmacology; 2022 Nov; 219():109250. PubMed ID: 36088985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus.
    O'Connor RM; Grenham S; Dinan TG; Cryan JF
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1885-92. PubMed ID: 23684180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H; Iijima M; Chaki S
    Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.
    Jett JD; Boley AM; Girotti M; Shah A; Lodge DJ; Morilak DA
    Psychopharmacology (Berl); 2015 Sep; 232(17):3123-33. PubMed ID: 25986748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine.
    Fukumoto K; Iijima M; Funakoshi T; Chaki S
    Int J Neuropsychopharmacol; 2018 Apr; 21(4):371-381. PubMed ID: 29309585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1.
    Zhang K; Yang C; Chang L; Sakamoto A; Suzuki T; Fujita Y; Qu Y; Wang S; Pu Y; Tan Y; Wang X; Ishima T; Shirayama Y; Hatano M; Tanaka KF; Hashimoto K
    Transl Psychiatry; 2020 Jan; 10(1):32. PubMed ID: 32066676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
    Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K
    Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine.
    Carreno FR; Donegan JJ; Boley AM; Shah A; DeGuzman M; Frazer A; Lodge DJ
    Mol Psychiatry; 2016 Sep; 21(9):1298-308. PubMed ID: 26619811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
    Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM
    Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.